Ofev — Medical Mutual
Interstitial Lung Disease Associated with Systemic Sclerosis
Initial criteria
- Patient is age ≥ 18 years; AND
- Forced vital capacity is ≥ 40% of the predicted value; AND
- Diagnosis is confirmed by high-resolution computed tomography; AND
- Medication is prescribed by or in consultation with a pulmonologist or a rheumatologist
Reauthorization criteria
- Patient is age ≥ 18 years; AND
- Patient has experienced a beneficial response to therapy over the last year while receiving Ofev (if < 1 year, response is from baseline prior to initiating Ofev); AND
- Medication is prescribed by or in consultation with a pulmonologist or a rheumatologist
Approval duration
1 year